MedPath

Evaluation of cerebral microembolism related to left atrial ablation of paroxysmal atrial fibrillatio

Conditions
I48.10
I63.4
Cerebral infarction due to embolism of cerebral arteries
Registration Number
DRKS00003465
Lead Sponsor
niversitätsklinikum Regensburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
65
Inclusion Criteria

1. Patients with paroxysmal atrial fibrillation scheduled for pulmonary vein isolation (PVI alone, no additional ablation)
2. Provided written informed consent

Exclusion Criteria

1. Age <18 and >80 years
2. Prior Stroke
3. Dementia
4. Prior pulmonary vein isolation
5. Severe claustrophobia
6. Implanted pacemaker/ICD (no MRI possible)
7. Persistent atrial fibrillation

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Composite endpoint of cerebral microembolisms demonstrated by cerebral magnetic resonance imaging (the day before and two days and one month after the procedure), microembolisms recorded by transcranial doppler (during the procedure) and neuropsychological events measured by trail making test A, trail making test B, controlled oral word association test, block tapping test und Ruff 2&7 test (the day before and two days and one month after the procedure).
Secondary Outcome Measures
NameTimeMethod
Influence of periprocedural management and technical settings on the occurence of cerebral microembolisms
© Copyright 2025. All Rights Reserved by MedPath